FOUNDATION fieldbus developments: Seminar, agreement to acquire fieldbus devices
Recent developments include a comprehensive FOUNDATION fieldbus-seminar hosted by Genzyme on Nov. 3-4 in Cambridge, MA, and Moore Industries International Inc. 's agreement to acquire fieldbus device couplers and power supplies from a U.K.-based company.
Genzyme's event will include hands-on instruction in the use of FOUNDATION fieldbus control-systems and feature presentations by fieldbus technology experts. At Genzyme, Tri-State University Technology Center will host a workshop covering fieldbus end-user applications in the pharmaceutical and biomedical industries. The workshop will describe implementation of the open, integrated FOUNDATION fieldbus H1 and High Speed Ethernet (HSE) automation architecture in life-sciences production environments.
Thursday's activities will also include an optional tour of Genzyme's Allston Landing manufacturing facility, which includes several hundred FOUNDATION fieldbus nodes. The 180,000-square-foot facility has bulk manufacturing capacity for multiple products utilizing recombinant mammalian-cell culture.
Included is an overview of the Fieldbus Foundation's global End User Councils (EUC), presentations concerning Electronic Device Description Language (EDDL) technology and fieldbus economic models, and an update on recent FF activities worldwide. Prominent end-user companies will also give presentations.
To register for the Cambridge seminar, click here .
In a related development, Moore Industries International has an agreement with U.K.-based Hawke International to acquire its FOUNDATION Fieldbus/Profibus PA device-couplers and fieldbus power-supplies.
Appearing under the new name of MooreHawke, the company's automatic segment-termination and unique split-architecture, I.S. power supplies will join existing offerings of distributed I/O, temperature sensors, transmitters, alarm trips, and signal conditioners.
— Richard Phelps, senior editor, Control Engineering